These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5775990)

  • 41. Multiple forms of monoamine oxidase: some in vivo correlations.
    Sandler M; Carter SB; Goodwin BL; Ruthven CR; Youdim MB; Hanington E; Cuthbert MF; Pare CM
    Adv Biochem Psychopharmacol; 1974; 12(0):3-10. PubMed ID: 4608403
    [No Abstract]   [Full Text] [Related]  

  • 42. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 43. Some structural requirements for inhibition of type A and B forms of rabbit monoamine oxidase by tricyclic psychoactive drugs.
    Roth JA; Gillis CN
    Mol Pharmacol; 1975 Jan; 11(1):28-35. PubMed ID: 1117864
    [No Abstract]   [Full Text] [Related]  

  • 44. Platelet enzyme abnormalities in neuropsychiatric disease.
    Farmer PM
    Ann Clin Lab Sci; 1980; 10(4):263-8. PubMed ID: 6108742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 46. In vivo measurement of brain serotonin turnover.
    Neff NH; Tozer TN
    Adv Pharmacol (1962); 1968; 6(Pt A):97-109. PubMed ID: 5664062
    [No Abstract]   [Full Text] [Related]  

  • 47. Monoamine uptake inhibitors.
    Ban TA
    Mod Probl Pharmacopsychiatry; 1982; 18():1-16. PubMed ID: 7048070
    [No Abstract]   [Full Text] [Related]  

  • 48. Uptake of debrisoquin and guanethidine by human blood platelets.
    Boullin DJ; O'Brien RA
    J Pharm Pharmacol; 1968 May; 20(5):403-4. PubMed ID: 4385451
    [No Abstract]   [Full Text] [Related]  

  • 49. Human blood platelet as research tool in neuropsychopharmacology.
    Bongioanni P; Dadone F; Donato M
    J Neural Transm Suppl; 1991; 33():65-71. PubMed ID: 1684381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressed uptake of serotonin by platelets in hepatic encephalopathy.
    Wardle EN; Williams R
    Biochem Med; 1980 Oct; 24(2):223-7. PubMed ID: 7458927
    [No Abstract]   [Full Text] [Related]  

  • 51. 6,7-Dihydroxytetrahydroisoquinoline: evidence for in vivo inhibition of intraneuronal monoamine oxidase.
    Cohen G; Katz S
    J Neurochem; 1975 Nov; 25(5):719-22. PubMed ID: 1194928
    [No Abstract]   [Full Text] [Related]  

  • 52. The relation of blood platelet survival and distribution to 14-C-serotonin distribution and excretion.
    Heyssel RM; Silver LJ; Wasson M; Brill AB
    Blood; 1967 Mar; 29(3):341-53. PubMed ID: 6019952
    [No Abstract]   [Full Text] [Related]  

  • 53. Preliminary observations on the metabolism of (1- 14 C)tyramine in man.
    Tacker M; Creaven PJ; McIsaac WM
    J Pharm Pharmacol; 1972 Mar; 24(3):247-9. PubMed ID: 4402788
    [No Abstract]   [Full Text] [Related]  

  • 54. Interaction between debrisoquine and phenylephrine in man.
    Allum W; Aminu J; Bloomfield TH; Davies C; Scales AH; Vere DW
    Br J Clin Pharmacol; 1974 Feb; 1(1):51-7. PubMed ID: 22454869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neurone.
    Silas JH; Tucker GT; Smith AJ; Fieller NR
    Br J Clin Pharmacol; 1980 Apr; 9(4):419-25. PubMed ID: 7378259
    [No Abstract]   [Full Text] [Related]  

  • 56. Influence of coronary dilators on the uptake of serotonin by human platelets and adrenaline by chromaffine granules.
    Grobecker H; Lemmer B
    Experientia; 1971 Mar; 27(3):299-301. PubMed ID: 5546650
    [No Abstract]   [Full Text] [Related]  

  • 57. Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.
    Riddle MA; Leckman JF; Cohen DJ; Anderson M; Ort SI; Caruso KA; Shaywitz BA
    J Neural Transm; 1986; 67(1-2):31-43. PubMed ID: 3465864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis.
    Wielosz M; Salmona M; de Gaetano G; Garattini S
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):59-65. PubMed ID: 1012348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The disposition of debrisoquine in hypertensive patients.
    Silas JH; Lennard MS; Tucker GT; Smith AJ; Malcolm SL; Marten TR
    Br J Clin Pharmacol; 1978 Jan; 5(1):27-34. PubMed ID: 619932
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.